Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Coronin-6 (CORO6) is an actin-binding cytoskeletal protein and a member of the coronin protein family, encoded by the CORO6 gene on human chromosome 17p11.2[2][3]. It is highly enriched in muscle tissue, especially at the neuromuscular junction, and plays a key role in clustering and anchoring acetylcholine receptors (AChRs) via interactions with F-actin, thereby stabilizing postsynaptic receptor complexes critical for efficient neurotransmission[1]. Studies show that Coronin-6 acts as a scaffolding protein, dependent on its coiled-coil and β-propeller domains, both for oligomerization and actin binding. Its expression is upregulated during muscle differentiation and after nerve denervation, and it may also be involved in specific responses to allergen exposure in airway epithelial cells[2]. Coronin-6 is conserved across eukaryotes, with close relation to other coronin proteins such as CORO1A and CORO1B[2]. There is currently no evidence that it is a direct therapeutic target, associated drug, biomarker, or presents safety concerns as a target[3][2][1].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Coronin-6 (CORO6).